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Abstract
Mitochondria play a fundamental role in the regulation of cell death during accumulation of oxi-
dants. High concentrations of atmospheric oxygen (hyperoxia), used clinically to treat tissue
hypoxia in premature newborns, is known to elicit oxidative stress and mitochondrial injury to
pulmonary epithelial cells. A consequence of oxidative stress in mitochondria is the accumula-
tion of peroxides which are detoxified by the dedicated mitochondrial thioredoxin system. This
system is comprised of the oxidoreductase activities of peroxiredoxin-3 (Prx3), thioredoxin-2
(Trx2), and thioredoxin reductase-2 (TrxR2). The goal of this study was to understand the role
of the mitochondrial thioredoxin system and mitochondrial injuries during hyperoxic exposure.
Flow analysis of the redox-sensitive, mitochondrial-specific fluorophore, MitoSOX, indicated
increased levels of mitochondrial oxidant formation in human adenocarcinoma cells cultured
in 95% oxygen. Increased expression of Trx2 and TrxR2 in response to hyperoxia were not
attributable to changes in mitochondrial mass, suggesting that hyperoxic upregulation of mito-
chondrial thioredoxins prevents accumulation of oxidized Prx3. Mitochondrial oxidoreductase
activities were modulated through pharmacological inhibition of TrxR2 with auranofin and
genetically through shRNA knockdown of Trx2 and Prx3. Diminished Trx2 and Prx3 expres-
sion was associated with accumulation of mitochondrial superoxide; however, only shRNA
knockdown of Trx2 increased susceptibility to hyperoxic cell death and increased phosphory-
lation of apoptosis signal-regulating kinase-1 (ASK1). In conclusion, the mitochondrial thi-
oredoxin system regulates hyperoxic-mediated death of pulmonary epithelial cells through
detoxification of oxidants and regulation of redox-dependent apoptotic signaling.
Introduction
Transitioning from an in utero environment to life outside the womb is marked by change
from a relatively hypoxic environment to an oxygen-rich atmosphere. Lungs of prematurely
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born infants are underdeveloped with fewer alveoli and lower expression of antioxidant en-
zymes [1]. Consequently, preterm infants are at a disadvantage in coping with this oxidative
transition, even before therapeutic interventions such as supplemental oxygen (hyperoxia) and
mechanical ventilation are considered. Bronchopulmonary dysplasia (BPD) is caused, in part,
by sustained oxygen therapy in preterm infants and is marked by alveolar simplification [2, 3].
Disrupted perinatal alveolar growth may be mediated by loss of alveolar type 2 (AT2) epithelial
cells through either apoptosis or altered programming associated with exposure to or recovery
from excess oxygen [4–6]. Hyperoxic cellular injuries are manifested in part through generation
and accumulation of reactive oxygen species (ROS) [7]. Although BPD is associated with pre-
maturity, ROS generation and oxidative injury to the alveolar epithelium is also a component of
additional lung diseases such as acute respiratory distress syndrome and acute lung injury [8].
Mitochondria are considered a major site of ROS production since ρ0 cells fail to generate
ROS during hyperoxic culture [9, 10]. Electron transport chain complexes I and III are likely
the predominant sources of mitochondrial ROS production during hyperoxic injury [11].
Although ROS accumulation may not be an absolute determinant, oxidants are thought to
promote hyperoxic-mediated cell death through activation of pro-apoptotic Bcl-2 family pro-
teins [12]. Cells deficient in Bax or Bak do not undergo apoptosis in response to hyperoxia [10,
13]. Furthermore, anti-apoptotic Bcl-2 proteins such as Bcl-XL and Mcl-1 can abrogate Bax-
dependent hyperoxic cell death [14–16]. Collectively, these data support a functional relation-
ship between respiring mitochondria and activation of pro-apoptotic Bcl-2 proteins which
may mediate susceptibility to hyperoxic cell death.
Multiple endogenous enzyme systems work in coordination based on both target specificity
and catalytic rate to maintain redox homeostasis in the mitochondrial matrix. Superoxide radi-
cal formed as a byproduct of oxidative phosphorylation (OXPHOS) is rapidly converted by
superoxide dismutase 2 (SOD2) to hydrogen peroxide. Peroxiredoxin-3 (Prx3) is the primary
oxidoreductase for reducing hydrogen peroxide in the matrix and reacts more efficiently than
either catalase or glutathione peroxidase. In fact, it is estimated that Prx3 scavenges 90% of
all peroxides in the mitochondrial matrix [17]. However, Prx3 can also reduce peroxynitrite,
alkylhydroperoxides, as well as peroxides found on amino acids and proteins [18]. Similar to
all 2-cysteine peroxiredoxins, the peroxidatic cysteine of Prx3 reacts with hydrogen peroxide
to first form a sulfenic acid intermediate. This subsequently forms a disulfide with a resolving
cysteine to form the oxidized Prx3 homodimer [19]. Regeneration of reduced monomeric Prx3
is dependent on thioredoxin-2 (Trx2), an enzyme which is recycled by thioredoxin reductase-2
(TrxR2) using electrons from NADPH. Because of its fundamental role in peroxide detoxifica-
tion, the oxidoreductase activity of Trx2 prevents mitochondrial-dependent cell death mediated
by various oxidant stimuli, including tert-butylhydroperoxide, etopiside, kanamycin, TNF-α,
and excitotoxicity [20–25]. One proposed mechanism of cytoprotection against oxidative dam-
age is that Trx2 binds and inhibits apoptosis signal-regulating kinase-1 (ASK1) [26, 27]. Trx2
oxidation or displacement by thioredoxin interacting protein (TXNIP) relieves ASK1 inhibition
which subsequently initiates caspase-dependent apoptosis [28]. Alternatively, Trx2 may directly
prevent activation of the mitochondrial permeability transition pore (MPTP) [23].
In this study we examined the role of Trx2 and Prx3 during hyperoxic injury in human
lung epithelial cells. Oxidized Trx2 and Prx3 accumulated during hyperoxia which was associ-
ated with increased mitochondrial ROS (mtROS). Furthermore, genetic or pharmacologic
inhibition of redox cycling via TrxR2 increased susceptibility to hyperoxic cell death and was
associated with generation of mtROS and activation of the MPTP. Only Trx2 disruption, and
not Prx3, correlated with activation of pro-apoptotic signaling via ASK1. Our data indicate
that Prx3 serves as a primary sensor of mtROS to relieve Trx2 inhibition of ASK1, thereby pro-
moting hyperoxic cell death.
Mitochondrial Thioredoxin System in Hyperoxia
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Materials and Methods
Cell Culture and Treatment
Human lung adenocarcinoma A549 [29] and H1299 [30] cells (obtained in October 2009 from
ATCC; CCL-185 and CRL-5803) were cultured in 5% CO2 at 37˚C in high glucose (25 mM)
DMEM with 10% fetal bovine serum, 50 U/mL penicillin, 50 μg/mL streptomycin and 20 μg/mL
gentamycin. During hyperoxic exposure, cells were cultured in a Plexiglas chamber flooded with
95% O2/5% CO2. For treatments, cells were pre-treated with indicated doses of MitoTEMPO
and auranofin (AFN; Sigma Aldrich) prior to hyperoxic exposure. During chronic exposures,
MitoTEMPO was supplemented every 24 hrs without changing culture media.
Flow Cytometry
Cells were pulsed with 5 μM MitoSOX Red or 1 nM TMRE (tetramethylrhodamine, ethyl
ester) and 10 nM TO-PRO-3 (Thermo Fisher Scientific). A minimum of 10,000 live events
were collected using an Accuri C6 (BD Biosciences) and analyzed using CSampler (BD Biosci-
ences) and FCS Express4 Flow Research edition software (DeNovo). For MitoSOX Red and
TMRE experiments, dyes were excited at 488 nm and emitted fluorescence was detected using
the FL2 (585/40 nm) and the FL3 (670 LP) filters, respectively.
SDS-PAGE & Immunoblot
As previously described [31], cell lysates were diluted in Laemmli buffer, separated by polyacryl-
amide gel electrophoresis (SDS-PAGE), and transferred to PVDF membranes. Membranes
were blocked in 5% non-fat dry milk before incubating overnight at 4˚C in rabbit polyclonal
anti-Trx2 (1:250, Santa Cruz, sc-50336), rabbit polyclonal anti-Prx3 (1:1,000, Thermo Fisher
Scientific, LF-PA0030), rabbit polyclonal anti-TrxR2 (1:1,000, Abcam, ab58445), rabbit poly-
clonal anti-ASK1 (1:500, Santa Cruz, sc-7931), rabbit polyclonal anti-pASK1 (1:1,000, Cell Sig-
naling, 3765), rabbit polyclonal anti-Bax (1:1,000, Santa Cruz, sc-493), mouse monoclonal anti-
Bak (1:1,000, EMD Millipore, AM03) or rabbit polyclonal anti-β-actin (1:1,000, Sigma Aldrich,
A2066). Membranes were then incubated with anti-rabbit or anti-mouse (1:5,000, Southern
Biotechnology) HRP-conjugated secondary antibodies and immune complexes were detected
by chemiluminescence captured and analyzed on a UVP bioimaging system (Upland, CA).
Semi-quantitative analyses of immunoblots were performed using Image Studio (LI-COR).
Quantitative Real-Time PCR (qPCR)
RNA was isolated using the SV Total RNA Isolation System (Promega). cDNA was synthesized
from samples with an RNA integrity number of 8.0 or greater evaluated with a 2100 Bioanalyzer
(Agilent Technologies). Primers and probes for qPCR were designed for human Prx3, Trx2,
TrxR2 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) using Beacon Designer 7.91
(Premier Biosoftware) (S1 Table). As previously described [31], primers (900 nM) and probes
(250 nM) were diluted in 2X Absolute Blue master mix (Thermo Fisher Scientific) and assayed
using a 7500 Real Time PCR System (ABI). Standard MIQE guidelines including internal
primer validation through mass normalization, assessment of genomic DNA contamination,
and assay efficiency were performed [32].
Mitochondrial Mass
To quantify variation in mitochondrial number as cells are cultured in hyperoxia, DNA was
isolated from A549 over a four day hyperoxic timecourse. Phenol/chloroform isolated DNA
was analyzed by real-time PCR using commercially available probes designed against the D-
Mitochondrial Thioredoxin System in Hyperoxia
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loop region of mitochondrial DNA and the COX1 mitochondrial gene (Fisher Scientific).
Input template was mass normalized and mitochondrial Ct values were normalized to the cor-
responding Ct values for β-2-microglobulin (β2M), a nuclear DNA target. Primers and probes
for β2M were designed to only amplify genomic DNA (S2 Table).
Redox Immunoblots
For Trx2 redox status, cells were lysed in 10% ice-cold trichloroacetic acid, washed in acetone,
and protein pellets were resuspended in 20 mM Tris-HCl (pH 8.0) containing 15 mM AMS
(4-acetoamido-40-maleimidylstilbene-2,20-disulphonic acid). Following AMS labeling, lysates
were diluted in non-reducing Laemmli buffer and subjected to SDS-PAGE/immunoblot [33].
Trx2 redox potential (Eh) was determined using the Nernst equation with E0 = -330 mV for
Trx2 at pH 7.6 and 25˚C [34]. For Prx3 analysis, cells were lysed in 100 mM N-ethylmaleimide
(NEM) alkylation buffer supplemented with 10 μg/mL catalase to label and retain reduced
monomers for non-reducing SDS-PAGE/immunoblot analysis [35].
Thioredoxin Reductase Activity Assay
For TrxR2 activity, a commercially available insulin reduction assay was utilized (Cayman Chem-
ical). Cells were harvested in assay buffer (0.1 M NaPO4, 5 mM EDTA, 0.1% Triton X-100, 1%
protease inhibitor cocktail (Sigma Aldrich), 1% phosphatase inhibitor cocktails 2 and 3 (Sigma
Aldrich), and 0.1 mM PMSF) and rotated for 2 hours at 4˚C. Lysates were then spun at 10,000
rpm for 15 minutes at 4˚C. Supernatants were collected and protein concentration was deter-
mined by BCA. Reductase activity was measured in a 96-well plate according to manufacturer’s
instructions. Absorbance was measured at 412nm using a Spectramax M5 microplate reader.
ShRNA Lentiviral Delivery
ShRNA sequences targeting human Trx2 and Prx3 as well as a non-targeting control were
designed using BLOCK-iT RNAi Designer software from Thermo Fisher Scientific (S3 Table)
and were cloned into the pLVX-shRNA2 (Clontech, Mountain View, CA). Following the man-
ufacturer’s instructions for the Lenti-X system, Lenti-X 293T cells were transfected with
pLVX-shRNA2 and HTX packaging mix to produce2.5x108 IFU/mL as determined by
qPCR. Cells were seeded in 6-well dishes and transduced with 0.5mL viral media supple-
mented with 8 μg/mL polybrene for 6 hours. Transduction efficiency after 48 hours was85%
by flow cytometry for ZsGreen1.
Statistical Analyses
Values represent mean ± standard deviation of biological replicates. Group means were com-
pared by 1-way ANOVA using Bonferroni’s post hoc test with GraphPad Prism 5 (GraphPad
Software). Statistical significance was defined as P0.05.
Results
Generation of Mitochondrial Oxidants during Hyperoxic Injury
MitoSOX was used as an indicator of mitochondrial oxidant generation during hyperoxic cul-
ture [36, 37]. Time-dependent increases in MitoSOX signal intensity were detected in A549
lung epithelial cells cultured in 95% oxygen (Fig 1A and 1B). Cell death following hyperoxia
was quantified using the cell-impermeable fluorescent dye, TO-PRO-3. TO-PRO-3 positive
cells were considered dead while debris was excluded from analysis (S1 Fig). Time-dependent
increases in cell death were observed over four days of hyperoxia which culminated in an
Mitochondrial Thioredoxin System in Hyperoxia
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11-fold increase in cell death after four days (Fig 1C). To determine if detoxification of mito-
chondrial superoxide alleviated hyperoxic cell death, additional viability experiments were
conducted during supplementation with the mitochondrial-targeted superoxide scavenger,
MitoTEMPO. Cells simultaneously treated MitoTEMPO and hyperoxia had significantly
reduced MitoSOX signal intensity and decreased cell death (Fig 1D and 1E). This data suggests
a crucial role for mitochondrial oxidation in hyperoxic cell death.
Hyperoxic Modulation of Trx2 and Prx3 Expression and Activity
Hydrogen peroxide accumulation results from dismutation of superoxide by SOD2 in the mito-
chondrial matrix [38]. Therefore, we hypothesized that the expression and redox state of Prx3,
Trx2, and TrxR2 may be altered as these redox enzymes function as a system to scavenge mito-
chondrial hydrogen peroxide. Transcript and protein expression of these genes were examined
in two human lung epithelial cell lines, A549 and H1299. Although Prx3 gene expression de-
creased by approximately 50% in both cell lines, surprisingly, Trx2 expression increased nearly
10-fold in hyperoxia (Fig 2A and 2B). This coincided with a significant, albeit smaller, increase
in TrxR2 expression (Fig 2C). Similar changes in Prx3, Trx2, and TrxR2 protein expression in
both cell lines were detected by immunoblot (Fig 3A and 3B) and quantified (S2 Fig).
Fig 1. Mitochondrial oxidants promote hyperoxic cell death. MitoSOX was used to quantify mitochondrial oxidants in A549 cells
cultured in hyperoxia. (A) MitoSOX red fluorescence intensity and (B) fold-change after 2 days of hyperoxic culture and during a
hyperoxic time course. (C) Hyperoxic cell death measured via flow cytometry using TOPRO-3. (D) Fold-change in MitoSOX red
fluorescence intensity of A549 cells after 2 days of hyperoxic culture with increased concentrations of MitoTEMPO supplemented in the
media. (E) Death of A549 cells cultured concurrently with 3 days hyperoxia and MitoTEMPO supplementation. Data are expressed as
mean ± standard deviation of 3 biological replicates analyzed by one-way ANOVA. Statistical significance was defined as *p<0.05,
**p<0.01, and †p<0.001.
doi:10.1371/journal.pone.0168777.g001
Mitochondrial Thioredoxin System in Hyperoxia
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One simple explanation for increased MitoSOX red fluorescence intensity and upregulation
of Trx2 and TrxR2 could be attributed to increased mitochondrial mass in response to extended
hyperoxic culture [39]. To investigate this possibility, mitochondrial and nuclear DNA were iso-
lated from A549 cells over four days of culture in hyperoxia. DNA was analyzed by real-time
PCR using probes designed against two regions of mitochondrial DNA (mtDNA): cytochrome C
oxidase 1 (COX1) and the control region (D-Loop) [40]. A primer and probe set were designed
to amplify genomic DNA of the β-2-microglobulin (β2M) gene. MtDNA Ct values were normal-
ized to corresponding β2M Ct values to derive mitochondrial:nuclear (mito:nuc) ratios for each
sample. As a control experiment validating this method, treatment with dideoxycytidine or
ethidium bromide expectedly decreased mito:nuc ratio determined by amplifying either D-Loop
or COX1 (S3 Fig). No significant changes in mito:nuc ratio for either of the two mitochondrial
genes were observed over the course of the hyperoxic exposure (Fig 4A and 4B). These data sug-
gest that hyperoxic upregulation of mitochondrial thioredoxins and increased MitoSOX red
fluorescence signal intensity are the consequence of a cellular response to increased production
of mitochondrial oxidants and are not due to changes in mitochondrial number.
The oxidation state of the catalytic cysteines in Prx3 and Trx2 was monitored by differential
thiol alkylation followed by SDS-PAGE. For Trx2 detection, free thiols were labeled with AMS,
which causes a mass shift in the reduced form (S4A Fig) [22, 34]. As expected, Trx2 was pre-
dominantly reduced under control conditions and became oxidized after 4 days of hyperoxic
culture (Fig 5A). Using the Nernst equation [34], Trx2 redox potential (Eh) was significantly
Fig 2. Oxygen-dependent gene expression of Prx3, Trx2, and TrxR2. qPCR analysis of (A) Prx3, (B)
Trx2, and (C) TrxR2 expression in A549 and H1299 cells during hyperoxic culture using GAPDH as a loading
control. Data are expressed as mean ± standard deviation of 3–4 biological replicates analyzed by one-way
ANOVA. Statistical significance was defined as *p<0.05, **p<0.01, and †p<0.001.
doi:10.1371/journal.pone.0168777.g002
Fig 3. Protein expression of mitochondrial redoxins Prx3, Trx2, and TrxR2 during hyperoxia. Representative
SDS-PAGE/immunoblots of cell lysates probed for Prx3, Trx2, and TrxR2 with β-actin as a loading control in (A)
A549 and (B) H1299 human lung adenocarcinoma cell lines cultured for increasing days in hyperoxia. Images are
representative of 3 independent biological replicates.
doi:10.1371/journal.pone.0168777.g003
Mitochondrial Thioredoxin System in Hyperoxia
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decreased during hyperoxia (Fig 5B). Oxidized Prx3 dimers were stabilized by alkylation of
free thiols with NEM, and detection of Prx3 monomers and dimers under non-reducing con-
ditions (S4B Fig) [35]. Prx3 oxidation is detected after 2 days of hyperoxia, which can be
expected based on the very fast kinetic rate for the neutralization of hydrogen peroxide by per-
oxiredoxins (Fig 5C and 5D) [17, 41]. It is important to note that these data do not conflict
with Prx3 expression as anti-peroxiredoxin antibodies are thought to have differential reactiv-
ity with oxidized and reduced forms [35].
Trx2 Prevents Hyperoxia-Induced Apoptotic Signaling
Pharmacologic and genetic approaches were used to determine if inhibition of Trx2 and/or
Prx3 activity augmented hyperoxic mitochondrial injuries. Auranofin (AFN), a thioredoxin
reductase inhibitor, is known to enter mitochondria, causing Prx3 oxidation (presumably via
inhibition of Trx2 redox cycling) and MPTP activation [35, 42, 43]. As expected, AFN exhib-
ited dose-dependent TrxR inhibition in A549 cells (Fig 6A). Culture in 2.5 μM AFN inhibited
91% of TrxR activity. Control cells cultured with AFN in room air had significantly increased
MitoSOX red fluorescence intensity. Hyperoxic treatment resulted in more robust fluorescent
signal which was not further exacerbated by AFN (Fig 6B). However, AFN supplementation
augmented hyperoxic-dependent cell death (Fig 6C). AFN does not have specificity for TrxR2
alone; rather, it inhibits TrxR1 as well. As such, AFN-mediated cell death in the absence of
increased MitoSOX red fluorescence may indeed be explained by TrxR1, and not TrxR2, inhi-
bition. Since cytosolic Trx1 is known to sensitize cells to hyperoxic damage [31], a second set
of experiments was conducted to genetically target Trx2 and Prx3 via RNAi knockdown. Cells
were transduced with lentivirus expressing a non-targeting control or Trx2 and Prx3 targeting
shRNAs. ShRNA delivery resulted in knockdown of the specific target without altering expres-
sion of the other key mitochondrial redox enzymes (Fig 6D). Knockdown of either Trx2 or
Prx3 caused increased MitoSOX red fluorescence intensity in control cells and had a similar
effect during hyperoxic culture (Fig 6E). Only knockdown of Trx2 caused increased hyper-
oxic-induced cell death (Fig 6F).
Based on the results of our viability experiments with Trx2 shRNA treatment during hyper-
oxia, we hypothesized that Trx2 knockdown may cause MPTP activation [23] and used TMRE
as an indicator of mitochondrial membrane potential (Δψm). Hyperoxic culture resulted in
Fig 4. Hyperoxia does not alter mitochondrial mass. Ratio of mitochondrial:nuclear Ct values for (A)
D-Loop and (B) COX1 after normalization to β2M quantified by qPCR in A549 during hyperoxic culture. Data
are expressed as mean ± standard deviation of 3 biological replicates analyzed by one-way ANOVA.
doi:10.1371/journal.pone.0168777.g004
Mitochondrial Thioredoxin System in Hyperoxia
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mitochondrial hyperpolarization (as opposed to depolarization and subsequent MPTP open-
ing), indicated by increased TMRE signal intensity (Fig 7A). To demonstrate specificity, TMRE
signal was ablated after incubation for 15 minutes with the proton ionophore, FCCP (carbonyl
cyanide 4-(trifluoromethoxy) phenylhydrazone), following hyperoxic culture (Fig 7A) [44].
However, mitochondrial hyperpolarization is associated with mitochondrial hypertrophy, a
hallmark of hyperoxic injury [45]. Knockdown of both Trx2 and Prx3 caused increased mito-
chondrial hyperpolarization in A549 cells cultured in room air and hyperoxia (Fig 7B).
Fig 5. Trx2 and Prx3 oxidation during hyperoxia. (A,C) Differential Trx2 and Prx3 thiol labeling by AMS and
NEM respectively, and (B,D) representative detection by SDS-PAGE/immunoblot in A549 cells after treatment with
hyperoxia. Images are representative of 3–4 independent biological replicates.
doi:10.1371/journal.pone.0168777.g005
Mitochondrial Thioredoxin System in Hyperoxia
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We also hypothesized that loss of Trx2 may cause susceptibility through loss of ASK1 inhi-
bition [26, 27, 46]. Cells cultured in hyperoxia had increased ASK1 phosphorylation at
Thr845, which coincided with increased expression of pro-apopototic Bax and Bak and
reduced expression of anti-apoptotic Bcl-XL and Mcl-1 (Fig 8A). Knockdown of Trx2 in
hyperoxia increased ASK1 phosphorylation with no change in expression of anti- and pro-
apoptotic Bcl-2 family proteins (Fig 8B).
Discussion
Apoptosis of alveolar epithelial cells is considered an important contributor to BPD pathogen-
esis [47]. Previous work has focused on molecular signals both converging on and being prop-
agated by mitochondria during hyperoxic cell death. Budinger et al. performed a comparative
study deleting genes activating intrinsic (Bax, Bak, Bim, Puma, Noxa) and extrinsic (FADD,
Bid) apoptotic signaling [48]. Only disruption of Bax and Bak improved survival of adult mice
and mouse embryonic fibroblasts subjected to 95% oxygen. Surprisingly, single deletion of
BH3-only (Bim, Puma, and Noxa) direct activators of Bax and Bak did not have any effect. It is
Fig 6. Trx2 inhibition sensitizes cells to hyperoxic cell death. (A) Inhibition of TrxR activity in A549 cells cultured for 24 hours with 1 or
2.5 μM AFN. (B) Fold-change in MitoSOX red fluorescence intensity after 2 days hyperoxic culture and (C) TO-PRO-3 labeling after 3 days
of hyperoxic culture with 1 or 2.5 μM AFN. (D) SDS-PAGE/immunoblot of A549 cell lysates for Trx2 and Prx3 protein expression 2 days
following lentiviral delivery of non-targeting (NT) and Trx2- or Prx3-targeting shRNAs. (E) Fold-change MitoSOX red fluorescence intensity
after 2 days of hyperoxia and (F) TO-PRO-3 labeling after 3 days hyperoxic culture following lentiviral transduction of NT, Trx2, or Prx3
shRNAs in A549 cells. Data are expressed as mean ± standard deviation of 3 biological replicates analyzed by one-way ANOVA. Statistical
significance was defined as *p<0.05, **p<0.01, and †p<0.001 (n = 3).
doi:10.1371/journal.pone.0168777.g006
Mitochondrial Thioredoxin System in Hyperoxia
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possible that BH3-only pathways resulting in activation of Bax and Bak during hyperoxia are
redundant and/or converge to repress anti-apoptotic Bcl-2 family proteins such as Bcl-XL,
Mcl-1, and Bcl-2 [49]. Since intrinsic apoptotic signaling via Bcl-2 family proteins is an impor-
tant determinant of hyperoxic cell death, we hypothesized that mitochondrial oxidoreductases
may serve as a signaling intermediate between intracellular oxidants generated during hyper-
oxia and injury/death pathways. Our data provide a unique contribution considering how
Trx2 and Prx3 function to facilitate electron flux for detoxification of mitochondrial oxidants
and regulation of injury signaling during hyperoxic exposure.
In agreement with previous reports, we demonstrate that mtROS directly contribute to oxy-
gen-induced cell death [9, 10]. Continuous MitoTEMPO treatment was able to detoxify mito-
chondrial superoxide radical generation which correlated with significantly reduced hyperoxic
cell death. Superoxide radical was detected with MitoSOX via flow cytometry, which increased
emitted red fluorescence by generation of the two-electron oxidation product, 2-hydroxymi-
toethidium, formed from MitoSOX interactions with superoxide radical [50]. MitoSOX carries
a net positive charge and preferentially reacts with superoxide to form 2-hydroxymitoethidium;
however, it is possible that a minor quantity of MitoSOX is oxidized by other routes. Reactions
with single electron oxidants, such as hydrogen peroxide and peroxidases, result in non-specific
oxidation of MitoSOX and produce mitohydroethidium, which also generates red fluorescence
[51]. The fluorescent spectra of 2-hydroxymitoethidium, the superoxide specific product, and
mitohydroethidium overlap. For this reason, in the context of this study, MitoSOX does not
provide a fully direct measure of superoxide production and activity. Rather, it is a sensor of
mitochondrial oxidants and suggests that hyperoxia augments generation of mitochondrial oxi-
dants and/or impairs their detoxification. While recognized as an indirect sensor, due to the
superoxide specificity of MitoTEMPO [52], these data support that MitoSOX reactivity was, in
large part, sensitive to hyperoxic generation of mitochondrial superoxide.
Although mitochondrial hyperpolarization and mtROS generation are associated with
MPTP activation [45], MPTP activation may not be required for hyperoxia-induced cell death.
Currently, cyclophilin D is the only defined regulatory component of the MPTP and mice defi-
cient in cyclophilin D had similar TUNEL-staining, lung pathology, and survival rates as wild-
type counterparts during hyperoxic injury [48]. ShRNA knockdown of either Trx2 or Prx3
resulted in increased mtROS and mitochondrial hyperpolarization during culture in both
Fig 7. Hyperoxia-induced mitochondrial hyperpolarization. (A) Fold-change in TMRE fluorescence
intensity of A549 cells cultured in hyperoxia in the absence or presence of 0.5 μM FCCP. (B) TMRE
fluorescence intensity after 3 days hyperoxic culture following lentiviral transduction of NT, Trx2, or Prx3
shRNAs in A549 cells. Data are expressed as mean ± standard deviation of 3 biological replicates analyzed
by one-way ANOVA. Statistical significance was defined as **p<0.01, and †p<0.001.
doi:10.1371/journal.pone.0168777.g007
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room air and hyperoxia. It is unknown if or how mtROS and mitochondrial hyperpolarization
are related during hyperoxic injury but both are likely influenced by bioenergetic changes. For
example, less ATP synthesized by OXPHOS during hyperoxic exposure may promote mito-
chondrial hyperpolarization [53, 54].
Trx2 activity, and not Prx3, was required for cytoprotection from hyperoxic cell death.
Reduced Trx2 binds to the N-terminal of ASK1, preventing serine/threonine kinase activity
[26]. Our data demonstrate that ASK1 phosphorylation increased during hyperoxic culture
and was exacerbated by Trx2 knockdown. As a MAP kinase kinase kinase, ASK1 signaling cul-
minates in JNK and p38 activation, both of which are associated with hyperoxic injury [55–
57]. Furthermore, ASK1-deficient mice had reduced lung injury when treated with large tidal
mechanical ventilation and hyperoxia [58]. Inhibitory Trx2 binding to ASK1 can be relieved
by overt thioredoxin oxidation or displacement via TXNIP binding [28, 59]. Although pulmo-
nary TXNIP may inhibit alveolar growth [60], we did not detect mitochondrial localization of
Fig 8. Trx2 inhibits hyperoxic phosphorylation of ASK1. Expression of pro-apoptotic proteins by SDS-PAGE/
immunoblot in A549 cells during (A) hyperoxic culture. (B) Immunoblots of lysates from A549 cultured in hyperoxia
for two days following lentiviral delivery of NT, Trx2, or Prx3 shRNAs. Images are representative of 3 independent
biological replicates.
doi:10.1371/journal.pone.0168777.g008
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TXNIP in A549 cells during hyperoxia (data not shown). ASK1 phosphorylation can also be
stimulated by TRAF2 and TRAF6 binding [61]. However, oxidative stimulation may also be
required to promote TRAF2 and TRAF6 binding, ASK1 dimerization, and autophosphorylation
at Thr845. Trx2 cytoprotection may also involve regulation of Bcl-2 family proteins. Knock-
down of Trx2 in DT40 cells caused loss of anti-apoptotic Bcl-XL but this was not dependent on
oxidoreductase activity [62]. Modulation of Bcl-XL levels is associated with injury outcomes in
hyperoxia [13–16], but we did not detect Trx2-dependent changes in Bcl-XL expression (Fig
8B). It is possible that ASK1 modulation may serve as a mechanistic link between Trx2 and the
Bcl-2 family proteins since Bcl-2 is phosphorylated by the ASK1:JNK MAPD signaling axis [63].
This leaves the possibility that post-translational modifications or localization changes in Bcl-2
family proteins is critical for Trx2-mediated cytoprotection from hyperoxic cell death.
Independent of precise apoptotic mechanisms, our data support that Prx3 acts as an oxidant
sensor to modulator Trx2 activity. The reactivity of MitoSOX with superoxide radical is likely
short-lived as it is dismutated to hydrogen peroxide by SOD2. Hydrogen peroxide can initiate
redox-dependent signaling changes through reversible oxidation of reactive protein thiols
[64]. Although cysteine oxidation by hydrogen peroxide is thermodynamically favorable,
direct oxidation of protein thiols is unlikely to occur as the kinetic rate is very slow (k ~1–10
M-1s-1) with the exemption of catalytic thiols of dedicated redox enzymes including catalase,
peroxiredoxins, glutathione peroxidases, and ascorbate peroxidases [17, 41, 65]. Prx3 reacts
with approximately 90% of mitochondrial peroxides due to abundance and kinetic activity
[17]. In contrast to the high buffering capacity of Prx3, Trx2 is present at much lower concen-
trations and is therefore a limiting factor more likely to serve as a threshold to initiate redox-
dependent signaling. As shown in Fig 9, under control conditions, reduction of molecular oxy-
gen by OXPHOS results in formation of mtROS which may be comprised of superoxide radi-
cal, hydrogen peroxide, and/or hydroxyl radical. Prx3 reduces mitochondrial peroxide and is
recycled by Trx2 and TrxR2 with electrons being ultimately donated from NADPH. Therefore,
Trx2 is primarily in a reduced state which exhibits selective inhibition of ASK1. During hyper-
oxic exposure, accumulation of mtROS and oxidation of Prx3 increases Trx2:TrxR2 redox
cycling which likely exhausts reducing equivalents of NADPH [41]. Hyperoxic depletion of
NADPH may also explain why overexpression of Trx2 did not reduce oxygen-induced cell
death (S5 Fig). Oxidation of Trx2 relieves ASK1 inhibition, resulting in subsequent ASK1
phosphorylation and activation of cell death. It is also possible that other Trx2 substrates serve
as mediators between Trx2 oxidation and ASK1 phosphorylation. Since oxidized Prx3 is
required to relieve Trx2 anti-apoptotic repression, this scheme describes why limiting either
Prx3 or Trx2 results in accumulation of mitochondrial peroxide while inhibition of only
Trx2 promotes hyperoxic cell death. Based on this mechanism, we propose that hyperoxic
Fig 9. Electron flux via Prx3 and Trx2 during hyperoxic injury. Schematic demonstrating mitochondrial electron
flux via the Prx3 and Trx2 under control and hyperoxic conditions.
doi:10.1371/journal.pone.0168777.g009
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upregulation of Trx2 and TrxR2 is an adaptive response to prevent accumulation of oxidized
Prx3 as the initiating damage signal. Although Wnt may influence TrxR2 expression [66], no
regulatory elements in the Trx2 promoter have been described and this is an important trajec-
tory of future research.
Since Prx3 and Trx2 do not exclusively metabolize mitochondrial peroxides, it is important
to consider how mitochondrial glutathione peroxidases (Gpx) function in response to hyper-
oxic injury. It is likely that peroxide metabolism and protein glutathionylation function in par-
allel in the mitochondria since depletion of glutathione results in Trx2 oxidation [67]. Loss of
Gpx1 did not increase mortality in adult mice treated with hyperoxia, further supporting a
redundant functional link between thioredoxin- and glutathione-dependent systems [68].
However, Trx2-deficient mice are not viable, marked by apoptosis beginning at E9.5, a time
coinciding with a metabolic shift to OXPHOS and likely increase in mtROS generation [69].
Exposure of newborn mice to short-term hyperoxia followed by recovery in room air reca-
pitulates many BPD pathologies including impaired alveolar and vascular growth with restric-
tive lung disease and early mortality attributed to pulmonary hypertension [5, 70–72]. A
possible explanation for these primary and subsequent phenotypes is that neonatal hyperoxia
reduces numbers of alveolar epithelial AT2 cells [4–6], which are known to serve as progenitor
cells during alveologenesis and alveolar repair [73]. Although it is possible that Trx2 mediates
AT2 cell death in vivo, it is unlikely that hyperoxic depletion of AT2 cells in the perinatal lung
can be explained exclusively by cell death. Yee et al. report that hyperoxia stimulates expression
of genetic markers indicative of alveologenesis and that AT2 cell numbers slowly diminish
during the recovery phase [6]. This exacerbated expansion of AT2 cells may be due to pro-
longed or enhanced activation of oxygen-dependent signaling pathways regulating perinatal
alveologenesis while transitioning to a more oxidative atmospheric environment outside the
womb. Therefore, altered AT2 programming may also contribute to BPD pathologies due to
accumulation of mitochondrial oxidants in the alveolar epithelium due to tissue hypoxia,
hyperoxic exposure, and recovery to room air. While hyperoxic injury has direct translational
implications in BPD, production of mtROS is an important component of oxidative lung dis-
eases including acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) [74,
75]. It is likely that Trx2 and Prx3 are similarly involved in maintenance of mtROS and apo-
ptotic signaling during ALI and ARDS which may mediate inflammatory signaling via mito-
chondrial release of damage-associated molecular patterns (DAMPs) [76].
Taken together, our data support that Trx2 activity is cytoprotective against hyperoxic
injury; however, these results obtained from adenocarcinoma cells may not accurately recapit-
ulate molecular physiologies in vivo due to redox and metabolic imbalances in cell culture
models [77, 78], and altered expression of Prx3, Trx2, or TrxR2 which will influence electron
flux [79]. Consistent with such differences, no changes in expression of Prx3, Trx2, or TrxR2
were detected in lungs of oxygen-exposed newborn mice (S6 Fig). Despite these preliminary
findings, we still speculate that future studies should consider accumulation of mitochondrial
peroxides and altered redox signaling as molecular mechanisms involved in AT2 program-
ming during lung development and oxidative lung injuries. In summary, these data support
that detoxification of mitochondrial oxidants was uncoupled from cytoprotection which we
hypothesize occurs through an ASK1 thiol switch regulated by Trx2 oxidation. Oxidized Prx3
accumulates during hyperoxic exposure and serve as the initiating event by exhausting redox
cycling of Trx2/TrxR2, thus relieving Trx2-dependent inhibition of ASK1 phosphorylation.
Prx3, Trx2, and TrxR2 function as a system to detoxify mitochondrial peroxides during hyper-
oxic injury although it is likely that their activities are coordinated with catalase, manganese
SOD, and Gpx1. Investigation of coordination between these pathways may reconcile conflict-
ing data from transgenic and knockout antioxidant enzyme mouse models [80, 81].
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Conclusions
We conclude that Prx3 and Trx2 comprise an adaptive system to sense changes in atmospheric
oxygen tension and influence cellular injury responses through both detoxification of mito-
chondrial oxidants and regulation of mitochondrial redox-dependent signaling.
Supporting Information
S1 Fig. Flow cytometric analysis of hyperoxic cell death. A549 cells were cultured in room
air or hyperoxia for four days. Viability was measured via flow cytometry by using TOPRO-3
as a marker of cell death (percentages indicate upper-quadrant distribution of cells).
(EPS)
S2 Fig. Protein quantification of mitochondrial redoxins Prx3, Trx2, and TrxR2 during
hyperoxia. Densitometric quantification of SDS-PAGE/immunoblots of oxygen-treated A549
and H1299 cell lysates probed for (A) Prx3, (B) Trx2, and (C) TrxR2 normalized to β-actin as a
loading. Data are expressed as mean ± standard deviation of 3 biological replicates analyzed by
one-way ANOVA. Statistical significance was defined as p<0.05, p<0.01, and †p<0.001.
(EPS)
S3 Fig. Decreased mitochondrial mass following ddC or EtBr treatment. Ratio of mito-
chondrial:nuclear Ct values for D-Loop and COX1 after normalization to β2M quantified by
qPCR in A549 cells following 5 days treatment with 20 μM dideoxycytidine (ddC) or 75 ng/mL
ethidium bromide (EtBr). Data are expressed as mean ± standard deviation of 3 biological repli-
cates analyzed by one-way ANOVA. Statistical significance was defined as p<0.01 and
†p<0.001.
(EPS)
S4 Fig. Detection of Trx2 and Prx3 oxidation. Differential (A) Trx2 and (B) Prx3 thiol label-
ing by AMS and NEM respectively.
(EPS)
S5 Fig. Trx2 overexpression does not prevent hyperoxic cell death. A C-terminal flag epi-
tope was introduced by PCR of Trx2 cDNA (NM_012473), ligated into the doxycycline-induc-
ible pBIG2i vector, and stably transfected into H1299 cells. (A) SDS-PAGE/immunoblot of
H1299 cell lysates for the Trx2-flag transgene 24 hours following culture in 2μg/mL doxycy-
cline (DOX). (B) Immunocytochemistry and mitochondrial co-localization of Trx2-flag. (C)
Viability of two H1299+Trx2-flag clones cultured in absence or presence of DOX and cultured
in hyperoxia for 3 days. Data are expressed as mean ± standard deviation and analyzed by one-
way ANOVA.
(EPS)
S6 Fig. Oxygen-dependent pulmonary expression of Prx3, Trx2, and TrxR2. C57Bl/6J new-
born litters (PND<0.5) were randomly placed in 85% oxygen or room air for the first seven
days of life. After seven days, room air or hyperoxic lungs were analyzed by qPCR using the
following Taqman probes: Txn2 (MM0044931_M1), Prdx3 (MM00545848_M1), Txnrd2
(MM00496766_M1), and HPRT (MM01545399_M1). Data are expressed as mean ± standard
deviation of 3–4 biological replicates analyzed by student’s t-test.
(EPS)
S1 Table. qPCR primer and probe sequences. qPCR primers and 6-carboxyfluorescein
(FAM)-labeled probe sequences targeting human Txn2, Prx2, TrxR2, and GAPDH.
(DOCX)
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S2 Table. qPCR primer and probe sequences for quantifying mitochondrial mass. Catalog
numbers and sequence for qPCR primers and 4,7,2-tricholo-7-phenyl-carboxyfluorescein
(VIC)-labeled probe sequences targeting human D-Loop, COX1, and β-2-microglobulin.
(DOCX)
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